Quest Diagnostics Incorporated
DGX
$178.36
$1.400.79%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 950.00M | 897.00M | 871.00M | 841.00M | 840.00M |
| Total Depreciation and Amortization | 543.00M | 517.00M | 493.00M | 467.00M | 453.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 229.00M | 185.00M | 171.00M | 149.00M | 121.00M |
| Change in Net Operating Assets | -44.00M | -105.00M | -201.00M | -60.00M | -166.00M |
| Cash from Operations | 1.68B | 1.49B | 1.33B | 1.40B | 1.25B |
| Capital Expenditure | -454.00M | -438.00M | -425.00M | -374.00M | -373.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.93B | -2.02B | -2.16B | -1.78B | -250.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.00M | 10.00M | 41.00M | -5.00M | -11.00M |
| Cash from Investing | -2.37B | -2.45B | -2.55B | -2.16B | -634.00M |
| Total Debt Issued | 2.25B | 2.06B | 1.85B | 2.74B | 1.45B |
| Total Debt Repaid | -1.00B | -903.00M | -303.00M | -720.00M | -1.32B |
| Issuance of Common Stock | 87.00M | 90.00M | 73.00M | 64.00M | 53.00M |
| Repurchase of Common Stock | -194.00M | -194.00M | -175.00M | -299.00M | -298.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -342.00M | -336.00M | -331.00M | -327.00M | -323.00M |
| Other Financing Activities | -48.00M | -42.00M | -26.00M | -69.00M | -29.00M |
| Cash from Financing | 746.00M | 676.00M | 1.08B | 1.38B | -469.00M |
| Foreign Exchange rate Adjustments | -2.00M | -6.00M | -7.00M | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.00M | -286.00M | -137.00M | 621.00M | 145.00M |